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Abstract
Background: There have been previous reported deaths due to clozapine-induced constipation.
In all these cases patients have experienced prior abdominal symptoms over a period of weeks or
months.
Case presentation: We report the sudden death due to constipation of a healthy young male
patient on clozapine without any known history of prior abdominal symptoms.
Conclusion: Psychiatrists need to be alert to the medical emergencies which can occur in the
context of clozapine treatment and also need to make other clinicians who may have contact with
their patients aware of these.
Background
There have been six previously published cases of death
secondary to clozapine-induced constipation [1-3]. Of
these, two patients died from faecal peritonitis, two from
aspiration of faeculent vomitus as a result of bowel
obstruction and two from bowel necrosis. In all these
cases there had been prior complaints of constipation
and/or other abdominal symptoms for weeks to months
before the fatal event. Here we describe a case of constipa-
tion, presumably clozapine-induced, where death from
bowel ischaemia occured within 2 days from the first
complaint of constipation and without any prior reported
abdominal symptoms which might have provided a warn-
ing to the clinicians involved.
Case presentation
A 20-year-old male with a year long history of schizophre-
nia which had been unresponsive to trials of two atypical
antipsychotic drugs was commenced on clozapine. The
dose was titrated over the next year to 900 mg daily. Due
to persisting negative symptoms amisulpiride 400 mg
twice daily was added with good response after one
month. The patient was reviewed regularly over the next
year, continued to improve and did not report any side
effects to members of the multidisciplinary mental health
team working to support him in the community. He
appeared to be fit and healthy. Although he usually lived
in supported accommodation he was staying temporarily
with his family and from their account he complained of
having constipation for 2 days before presenting to his GP
with severe abdominal pain. He was prescribed medica-
tion and returned home but his condition deteriorated
further and a few hours later an ambulance was called. He
collapsed and died before reaching hospital. Post mortem
examination revealed that he had impacted faeces which
had pressed against the bowel wall causing ischaemia.
This had led to infarction of this part of the bowel.
Conclusion
This case demonstrates that death can occur over a very
short time course from constipation, in this case presum-
ably induced by clozapine. Death from constipation and
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subsequent bowel infarction is relatively common in eld-
erly patients and infarction causes a far more rapid and
dangerous deterioration than does intestinal obstruction.
In the present case this meant that this patient did not
have any contact with psychiatric services between the
onset of his symptoms and his rapid demise, in spite of
regular follow-up. Although the risk of neutropenia is rel-
atively well-known, it should be borne in mind that cloz-
apine is reported to be associated with a number of other
syndromes which may be rapidly fatal including not only
constipation and obstruction but also cardiovascular col-
lapse, seizures and ketoacidosis. Psychiatrists working
with such patients should not only themselves be vigilant
regarding such complications but should take steps to see
that other clinicians to whom the patient may present are
also aware of them.
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